Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2022

Primary Completion Date

August 15, 2023

Study Completion Date

October 5, 2023

Conditions

Asthma

Interventions

DRUG

UPB-101

Subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Trial Locations (4)

Hammersmith Medicines Research, London

Queen Anne Street Medical Centre, London

Richmond Pharmacology, London

Medicines Evaluation Unit, Manchester

All Listed Sponsors

lead

Upstream Bio Inc.

INDUSTRY